England’s Innovative Medicines Fund To Put Spotlight On Rare Disease Treatments
Executive Summary
While the much-anticipated Innovative Medicines Fund is likely to benefit rare diseases in particular, other products must gain too.
You may also be interested in...
England Launches Innovative Medicines Fund
The new financing mechanism promises faster access to new treatments, but some industry concerns remain unresolved.
England Unveils £680m Innovative Medicines Fund
England’s Innovative Medicines Fund is aimed at providing earlier access to promising new treatments, including gene therapies, when further data is needed for routine commissioning.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.